Naoki Morishita Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

1/2022	Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis.
5/2019	Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response.
8/2018	Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C.
2/2014	Significance of liver stiffness measurement by acoustic radiation force impulse (ARFI) among hepatitis C patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoki Morishita Research Topics

Disease

7	Chronic Hepatitis C 01/2023 - 02/2014
7	Infections 01/2020 - 07/2015
6	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 07/2015
5	Fibrosis (Cirrhosis) 04/2023 - 02/2014
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 02/2014
3	Cataract (Cataracts) 01/2023 - 01/2020
2	Neoplasms (Cancer) 01/2024 - 01/2004
2	Presbyopia 01/2023 - 03/2021
2	Hepatitis C 05/2019 - 12/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2024
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022
1	Age-Related Nuclear Cataract 03/2021
1	Hepatitis 12/2017
1	Hyperbilirubinemia 03/2016
1	Virus Diseases (Viral Diseases) 11/2015
1	Chronic Hepatitis B 07/2015
1	Exanthema (Rash) 03/2015
1	Anemia 03/2015
1	Hemobilia 12/2013
1	Jaundice (Icterus) 12/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2013
1	Acute Abdomen 12/2013
1	False Aneurysm (Pseudoaneurysm) 12/2013
1	Neoplasm Metastasis (Metastasis) 01/2004
1	Colonic Neoplasms (Colon Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

6	Antiviral Agents (Antivirals)IBA 01/2023 - 02/2014
5	InterferonsIBA 05/2019 - 02/2014
5	Ribavirin (Virazole)FDA LinkGeneric 12/2017 - 02/2014
4	SofosbuvirIBA 04/2023 - 11/2015
3	hesperetinIBA 01/2023 - 01/2020
3	SimeprevirIBA 07/2017 - 03/2016
2	atezolizumabIBA 01/2024 - 01/2023
2	Bevacizumab (Avastin)FDA Link 01/2024 - 01/2023
2	Fetal Proteins (Fetoprotein)IBA 01/2024 - 05/2019
2	ledipasvirIBA 08/2018 - 11/2015
2	sofosbuvir drug combination ledipasvirIBA 08/2018 - 12/2017
2	telaprevirIBA 07/2017 - 03/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2014 - 02/2014
1	velpatasvirIBA 04/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Advanced Glycation End ProductsIBA 01/2023
1	flavanoneIBA 01/2023
1	Crystallins (Crystallin)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	AlbuminsIBA 01/2022
1	HaptoglobinsIBA 01/2022
1	glucosyl hesperidinIBA 03/2021
1	EnzymesIBA 03/2021
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 03/2021
1	Messenger RNA (mRNA)IBA 03/2021
1	Sodium SeleniteIBA 03/2021
1	Selenious Acid (Selenite)IBA 03/2021
1	Thioredoxin Reductase 1IBA 03/2021
1	asunaprevirIBA 01/2020
1	daclatasvirIBA 01/2020
1	HesperidinIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Inosine Triphosphate (ITP)IBA 03/2016
1	PyrophosphatasesIBA 03/2016
1	BilirubinIBA 03/2016
1	NucleotidesIBA 11/2015
1	Shiga Toxin (Shigella Toxin)IBA 08/2015
1	entecavir FDA Link 07/2015
1	Hepatitis B e AntigensIBA 07/2015
1	NucleosidesIBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 07/2015
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2015
1	Hemoglobins (Hemoglobin)IBA 03/2015
1	CyanoacrylatesIBA 12/2013
1	Protons (Proton)IBA 12/2013
1	Gemcitabine FDA Link 12/2013
1	src-Family KinasesIBA 01/2004
1	IntegrinsIBA 01/2004

Therapy/Procedure

6	Therapeutics 01/2024 - 02/2014
1	Retreatment 07/2017
1	Drug Therapy (Chemotherapy) 12/2013
1	Radiotherapy 12/2013
1	Stents 12/2013